Search

Search Constraints

You searched for: Author/Creator Garcia, Jorge A.

Search Results

1. A phase 2, single‐arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor therapy. Issue 11 (27th February 2014)

2. A phase 2, single‐arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor therapy. Issue 11 (27th February 2014)

3. A phase II trial of intermittent nivolumab in patients with metastatic renal cell carcinoma (mRCC) who have received prior anti-angiogenic therapy. Issue 1 (16th May 2019)

5. Association between baseline body mass index and survival in men with metastatic hormone‐sensitive prostate cancer: ECOG‐ACRIN CHAARTED E3805. Issue 12 (10th May 2022)

6. Cardiovascular Events in Men with Prostate Cancer Receiving Hormone Therapy: An Analysis of the FDA Adverse Event Reporting System (FAERS). Issue 3 (19th September 2021)

7. Clinical activity of nivolumab in patients with non-clear cell renal cell carcinoma. Issue 1 (29th January 2018)

8. Evaluation of T cell infiltration in matched biopsy and nephrectomy samples in renal cell carcinoma. Issue 37 (September 2018)

9. Impact of Maximal Transurethral Resection on Pathological Outcomes at Cystectomy in a Large, Multi-institutional Cohort. Issue 5 (16th May 2023)

10. MP27-13 LONG-TERM SAFETY OF DAROLUTAMIDE AMONG PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER WHO RECEIVED MORE THAN 4 YEARS OF THERAPY. (May 2022)